PEI Regulatory Approval Received for Government Funded (€ 7.4 Million) Clinical Trial Investigating Adrenomed’s Adrecizumab in Treating Endothelial Barrier Dysfunction in Hospitalized COVID-19 Patients

Adrecizumab selected to receive funding from two COVID-19 drug development programs of the German Federal Ministry of Education and Research (BMBF)

By restoring vascular integrity, Adrecizumab addresses the endothelial barrier dysfunction as a…

3 Min
More

BIO International Convention in San Diego,CA

Meet the German Capital Region at BIO International Convention in San Diego, June 13-18, San Diego Convention Center | German Pavilion | Booth #4617

1 Min
More

Eckert & Ziegler: Radboud University Medical Center Netherlands to Image First Patient with PENTIXAFOR

 

Berlin / Nijmegen, 8 April 2022. Radboud University Medical Center (RUMC) in Nijmegen, one of the largest centres of excellence in the Netherlands for adrenal diseases, treated the first patient with primary aldosteronism with the Ga-68-based…

4 Min
More

Charité researchers identified a large number of specific genes which play a key role in the onset and development of schizophrenia

Study published in Nature shows mental disorder associated with specific genes

 

3 Min
More

Speed Lecture Award 2022 finals on May 11th in Berlin: our shortlist candidates

We proudly announce the Speed Lecture Award finalists in 2022 that had been selected by the jury. Congratulations to all of them and good luck for your final performance on May 11th at Urania Berlin!

2 Min
More

Combination of wearable data and digital questionnaires: FeMFit study by Data4Life opens up new paths in research on female health

Potsdam (Germany), 05.04.2022. The Potsdam-based company Data4Life is expanding its research activities around the collection of real-world data. In January 2022, the non-profit organization launched the digital female health study FeMFit…

3 Min
More

Insertable Cardiac Monitors (ICM) and Remote Monitoring May Improve Outcomes for Post-Myocardial Infarction Patients, Study Demonstrates

Presentation at ACC.22 shows early treatment of high-risk NSTEMI patients guided by continuous arrhythmia monitoring with ICMs may reduce major adverse cardiac events (MACE)

 

2 Min
More

Eckert & Ziegler with Record Results in FY 2021 and Positive Outlook

 

Berlin, 30 March 2022. Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, TecDAX) achieved sales of EUR 180.4 million in fiscal year 2021 (previous year: EUR 176.1 million). The consolidated net income for the year reached a new…

2 Min
More

Bayer to strengthen global Pharmaceuticals production network

Planned investments of around €2bn over next three years / Shift of resources into strategic pharmaceutical areas by investing in key production sites, manufacturing technologies and supply chain network / Bayer is transforming its pharmaceutical…

4 Min
More

BIOTRONIK Patient App Facilitates Digital Patient Engagement

BIOTRONIK Patient App is available for patients with a compatible BIOTRONIK cardiac device

 

2 Min
More
Show more items